MusclePharm® Corporation (OTCBB:MSLP)
MusclePharm(NYSE:R) Corporation, one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in its portfolio of performance products, today announced UFC star Jake Shields will be wearing MusclePharm apparel at the UFC 121 co-main event, which takes place on October 23 from the Honda Center in Anaheim, California.
UFC 121 Matches draw an estimated 850,000 pay per view buys and is watched by an estimated 10 million viewers.
“UFC has been a tremendous partner for our company, and the exposure we will receive Saturday night addresses the perfect demographic for our brand. We are very excited to have one of our MMA athletes featured as the co-main event,” commented Cory Gregory, MusclePharm’s President. “This branding opportunity with UFC will further increase MusclePharm’s brand awareness and expand MusclePharm’s supplement and apparel market penetration.”
Shields (25-4-1) is in the midst of an impressive 14-fight win streak, with wins over decorated veterans including Yushin Okami, Carlos Condit, Paul Daley, Robbie Lawler, Jason “Mayhem” Miller and Dan Henderson during that stretch.
In his last fight, which took place under the Strikeforce banner, he defeated Henderson by decision. It was the last fight under his contract, however, and despite being the Strikeforce middleweight champ, he abandoned the belt to sign with the UFC as a free agent. Upon moving to the UFC, he returned to the 170-pound division, in which he’s spent most of his career.
Jake Shields is the number 1 contender at 170 weight class, and with a win Saturday night he is expected to be next in line for the title shot.
Nucor Corporation (NYSE:NUE) increased 1.00% to close at $38.26. NUE traded 3.55 million shares for the day and its earning per share remained $0.64. Nucor Corporation (Nucor) along with its affiliates is engaged in the business of manufacturing of steel and steel products, with operating facilities and customers primarily located in North America. The Company operates in three business segments: steel mills, steel products and raw materials. During the year ended December 31, 2009, the Company recycled approximately 13.4 million tons of scrap steel. The principal products from the steel mills segment are hot-rolled steel (angles, rounds, flats, channels, sheet, wide-flange beams, pilings, billets, blooms, beam blanks and plate) and cold-rolled steel.
ArcelorMittal (ADR) (NYSE:MT) increased 0.78% to close at $34.81. MT traded 4.08 million shares for the day and its earning per share remained $2.80. ArcelorMittal is a global steel producer. The Company has steel-making operations in 20 countries on four continents, including 65 integrated, mini-mill and integrated mini-mill steel-making facilities. ArcelorMittal operates its business in six operating segments: Flat Carbon Americas; Flat Carbon Europe; Long Carbon Americas and Europe; Asia, Africa and Commonwealth of Independent States (NYSE:CIS) (AACIS); Stainless Steel, and ArcelorMittal Steel Solutions and Services. Approximately 35% of its steel is produced in the Americas, approximately 47% is produced in Europe and approximately 18% is produced in other countries, such as Kazakhstan, South Africa and Ukraine.
Pactiv Corporation (NYSE:PTV) decreased 0.06% to close at $33.15. PTV traded 1.63 million shares for the day and its earning per share remained $2.15. Pactiv Corporation (Pactiv), incorporated in 1965, is a producer of consumer and foodservice/food packaging products. The Company’s business operates 43 manufacturing facilities in North America, and 1 in Germany. It also has two joint-venture interests in China. During the year ended December 31, 2009, 96% of its sales were generated in North America. The Company has three segments: Consumer Products, Foodservice/Food Packaging and Other. The Company manufactures disposable plastic, foam, molded fiber, pressed paperboard, and aluminum packaging products, and sells them to customers, such as grocery stores, mass merchandisers, and discount chains.
Sign-Up For Free Stock Alerts At http://crwepicks.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. The fee may be in cash, in free trading stock, in restricted stock, or in any combination thereof. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings, Inc. (OTCPK:CRWE) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (OTCQB:MSLP).